Nuvation Bio NUVB Cash Flow Statement (2020-2026)

NYSE NUVB
$6.81 +0.04 (+0.59%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Nuvation Bio Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

Nuvation Bio reported cash from operations of -$43.00M and free cash flow of -$43.00M for the quarter ended Jun 2026, up 10.7% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-21.98M-25.13M-21.29M-34.86M-27.20M-20.84M-21.73M-20.64M-19.65M-13.79M-14.79M-462.49M-41.21M-49.45M-53.24M-59.01M-55.79M5.10M5.40M-62.84M
Share-based Compensation
11.26M2.80M19.55M21.23M23.40M4.99M30.91M33.21M32.85M3.72M38.22M52.69M56.73M10.19M77.44M77.65M77.07M7.99M85.09M81.61M
Gains from Investment Securities
-0.12M-3.90M-6.32M-3.08M-0.46M-0.32M-0.14M0.27M-0.38M-0.24M1.46M-1.14M-0.53M1.15M0.75M-0.45M-0.61M1.13M-2.87M
Change in Interest Receivables
-0.18M1.23M-0.55M0.17M-0.32M0.14M-0.21M0.52M0.24M0.67M0.58M-0.39M0.24M-0.57M1.48M-1.07M1.54M-2.24M-0.02M0.63M
Cash from Operations
-13.15M-23.48M-24.93M-26.92M-28.09M-16.17M-19.33M-17.48M-16.16M-15.03M-15.70M-37.32M-31.09M-46.30M-42.63M-48.18M-52.90M-29.73M5.10M-43.00M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges
0.02M0.21M0.42M0.32M0.35M
Depreciation & Amortization (CF)Depreciation & Amortization
0.07M0.06M0.05M0.05M0.06M0.05M0.06M0.06M0.06M0.06M0.06M0.24M0.16M0.22M0.31M0.36M0.53M0.54M0.54M0.54M
Change in Working Capital
Change in Receivables
0.12M-0.01M12.61M-12.31M2.28M5.63M7.75M6.65M5.10M
Change in Account Payables
0.64M-1.17M5.75M3.06M-9.73M-0.86M0.81M-0.37M-0.20M-0.16M0.23M-3.02M7.17M-6.03M4.19M11.88M-7.06M-5.88M12.96M-9.85M
Change in Accured Expenses
2.61M3.99M-5.02M0.48M2.31M-0.10M-1.45M1.19M2.30M-2.06M1.51M-5.53M3.53M7.33M-8.94M0.11M8.58M12.60M-12.32M13.77M
Other Working Capital Changes
0.63M
Investing Activities
Capital Expenditures
0.03M0.14M0.01M0.20M0.10M0.07M0.01M0.02M0.55M0.49M-0.31M5.86M-0.14M0.40M7.75M-3.78M
Sales of Property, Plant and Equipment
0.01M0.01M
Acquisitions
-0.00M
Change in Acquisitions & Divestments
31.48M65.32M126.12M157.83M184.22M115.94M184.98M244.20M101.27M181.90M135.98M115.28M114.93M83.89M114.96M136.73M78.53M132.07M38.56M73.94M
Cash from Investing Activities
-91.72M-189.26M-5.55M-15.53M106.37M-21.83M-52.00M37.35M-9.59M33.16M7.54M34.27M29.12M51.77M54.18M54.88M-96.62M87.08M-43.64M5.99M
Financing Activities
Other financing activities
0.31M0.06M0.26M0.31M0.30M0.08M0.02M6.30M3.21M7.63M1.08M0.76M0.56M9.50M0.91M57.78M
Debt Issuance and Repayment
Long-Term Debt Issuances
Short-Term Debt issuances
5.57M11.20M
Change in Capital Stock
Net Shares Issued and Repurchased
2.47M9.25M16.47M8.87M11.09M8.74M20.18M21.97M24.89M12.75M
Misc.
Cash from Financing Activities
-0.03M0.54M4.26M-3.60M0.26M0.41M0.30M0.13M0.08M0.12M0.02M2.75M-1.54M-0.90M0.55M193.42M0.50M8.06M0.04M170.53M
Exchange Rate Effect
0.08M-0.74M1.12M0.15M-0.13M-0.06M-0.22M-0.17M-0.34M
Change in Cash
-104.90M-212.21M-26.22M-3.89M36.37M-37.59M-71.03M19.99M-25.67M18.25M-8.14M-0.23M-4.25M5.69M12.25M199.99M-149.07M65.19M-38.70M133.21M
Free Cash Flow
-13.18M-23.62M-24.94M-27.11M-28.20M-16.23M-19.34M-17.51M-16.71M-15.03M-16.19M-37.32M-30.77M-52.16M-42.48M-48.58M-60.64M-29.73M8.88M-43.00M
Net Cash Flow
-104.90M-212.21M-26.22M-46.05M78.53M-37.59M-71.03M19.99M-25.67M18.25M-8.14M-0.30M-3.51M4.57M12.10M200.12M-149.01M65.42M-38.49M133.52M